• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combination chemo-immunotherapy in advanced oesophageal squamous cell carcinoma.

作者信息

Sjoquist Katrin Marie

机构信息

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW 1450, Australia.

出版信息

Lancet Oncol. 2023 May;24(5):419-420. doi: 10.1016/S1470-2045(23)00151-1. Epub 2023 Apr 17.

DOI:10.1016/S1470-2045(23)00151-1
PMID:37080221
Abstract
摘要

相似文献

1
Combination chemo-immunotherapy in advanced oesophageal squamous cell carcinoma.晚期食管鳞状细胞癌的联合化疗免疫疗法
Lancet Oncol. 2023 May;24(5):419-420. doi: 10.1016/S1470-2045(23)00151-1. Epub 2023 Apr 17.
2
Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma.鱼藤素，一种用于人类食管鳞状细胞癌的新型抗肿瘤剂。
EBioMedicine. 2017 Dec;26:10. doi: 10.1016/j.ebiom.2017.11.010. Epub 2017 Nov 16.
3
Immunotherapy for Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌的免疫疗法
Curr Oncol Rep. 2017 May;19(5):33. doi: 10.1007/s11912-017-0590-9.
4
Prolonging Survival in Advanced Esophageal Squamous Cell Carcinoma With Immune Checkpoint Inhibitors.免疫检查点抑制剂延长晚期食管鳞状细胞癌患者生存期
Gastroenterology. 2022 Aug;163(2):527. doi: 10.1053/j.gastro.2022.05.042. Epub 2022 Jun 2.
5
Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma.免疫检查点抑制剂在晚期食管鳞状细胞癌患者中的疗效证据
JAMA Oncol. 2023 Jul 1;9(7):1004-1005. doi: 10.1001/jamaoncol.2023.0972.
6
Camrelizumab plus apatinib successfully treated a patient with advanced esophageal squamous cell carcinoma.卡瑞利珠单抗联合阿帕替尼成功治疗晚期食管鳞癌患者。
Immunotherapy. 2020 Nov;12(16):1161-1166. doi: 10.2217/imt-2020-0197. Epub 2020 Aug 20.
7
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial.卡瑞利珠单抗联合阿帕替尼二线治疗晚期食管鳞癌（CAP 02）：一项单臂、开放标签、Ⅱ期临床试验。
Lancet Gastroenterol Hepatol. 2022 Mar;7(3):245-253. doi: 10.1016/S2468-1253(21)00378-2. Epub 2022 Jan 6.
8
Combination immune checkpoint inhibition for older patients with oesophageal squamous cell cancer.老年食管鳞状细胞癌患者的联合免疫检查点抑制治疗
Lancet Healthy Longev. 2022 Jun;3(6):e372-e373. doi: 10.1016/S2666-7568(22)00126-X. Epub 2022 Jun 9.
9
Is chemotherapy for advanced or metastatic oesophageal squamous cell carcinoma no longer needed?晚期或转移性食管鳞状细胞癌不再需要化疗了吗？
Lancet Oncol. 2020 Jun;21(6):743-745. doi: 10.1016/S1470-2045(20)30182-0.
10
Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives.晚期食管鳞状细胞癌的抗程序性死亡蛋白1免疫疗法：期待已久的突破终于到来。
J Formos Med Assoc. 2020 Feb;119(2):565-568. doi: 10.1016/j.jfma.2019.10.010. Epub 2019 Oct 23.

引用本文的文献

1
Tertiary lymphoid structures correlate with the therapeutic efficacy and prognosis of resectable esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy plus immunotherapy.三级淋巴结构与接受新辅助放化疗加免疫治疗的可切除食管鳞状细胞癌的治疗效果和预后相关。
Front Immunol. 2025 Aug 22;16:1616247. doi: 10.3389/fimmu.2025.1616247. eCollection 2025.
2
Esophagectomy for very low body weight: a case report and literature review.极低体重患者的食管切除术：一例病例报告及文献综述
Front Oncol. 2025 Jun 23;15:1524764. doi: 10.3389/fonc.2025.1524764. eCollection 2025.
3
Cost-effectiveness of the addition of sintilimab as a first-line therapy for locally advanced or metastatic oesophageal squamous cell carcinoma: a Chinese healthcare system perspective.
从中国医疗保健系统角度看，信迪利单抗作为局部晚期或转移性食管鳞状细胞癌一线治疗药物的成本效益
Health Econ Rev. 2025 Jan 10;15(1):2. doi: 10.1186/s13561-024-00588-2.